Obesity surgery
-
Randomized Controlled Trial Comparative Study Clinical Trial
Nitrous oxide and laparoscopic bariatric surgery.
Nitrous oxide (N2O) is frequently used to supplement more potent anesthetic agents. One side-effect of N2O is its ability to expand an air-containing space. We investigated if N2O adversely affected operating conditions by distending normal bowel during laparoscopic bariatric procedures. ⋯ We found that using N2O did not cause noticeable bowel distention during laparoscopic bariatric procedures of relatively short duration.
-
Randomized Controlled Trial Clinical Trial
Beneficial effects of humidified, warmed carbon dioxide insufflation during laparoscopic bariatric surgery: a randomized clinical trial.
Recent data has shown that the use of warmed, humidified carbon dioxide (CO2) insufflation during laparoscopic surgery may be associated with better outcomes. ⋯ The use of warmed, humidified CO2 insufflation in bariatric patients undergoing LRYGBP was not associated with any significant benefit with regards to postoperative pain.
-
Randomized Controlled Trial Clinical Trial
Laryngoscopy and morbid obesity: a comparison of the "sniff" and "ramped" positions.
The effect of patient position on the view obtained during laryngoscopy was investigated. ⋯ The "ramped" position is superior to the standard "sniff" position for direct laryngoscopy in morbidly obese patients.
-
Randomized Controlled Trial Comparative Study Clinical Trial
Post-anesthesia recovery after infusion of propofol with remifentanil or alfentanil or fentanyl in morbidly obese patients.
The type of opioid used during general anesthesia in the morbidly obese influences recovery and the postoperative period. In a randomized clinical trial, the postoperative recovery profile and early period after general anesthesia with remifentanil, fentanyl and alfentanil were compared in morbidly obese patients. ⋯ In morbidly obese individuals, alfentanil or fentanyl and remifentanil can be safely used, but there is a higher rate of PONV and postoperative pain in the remifentanil group.
-
Randomized Controlled Trial Comparative Study Clinical Trial
Use of anti-emetics after intragastric balloon placement: experience with three different drug treatments.
Tropisetron treatment was compared with alizapride treatment. The secondary aim was to assess whether droperidol supplement would still improve the therapeutic outcome of tropisetron. ⋯ To decrease the incidence of vomiting in patients undergoing intragastric balloon placement, tropisetron proved to be the most effective antiemetic. A supplement of droperidol gave no better results but impaired postoperative mood and wellbeing. Alizapride was least effective.